CERo Therapeutics Holdings, Inc. (CERO)
(Delayed Data from NSDQ)
$7.96 USD
-0.15 (-1.79%)
Updated Aug 8, 2025 03:59 PM ET
After-Market: $7.96 +0.01 (0.06%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
CERo Therapeutics Holdings, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CERO 7.96 -0.15(-1.79%)
Will CERO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CERO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CERO
CERO Maintains Buy Rating with $30 Target Price by D. Boral Capital | CERO Stock News
CERO Advances in Clinical Trial for Acute Myeloid Leukemia Treatment
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 | CERO Stock News
Cero Therapeutics doses second patient in Phase 1 CER-1236 trial
CERO Stock Offering Proceeds Not Benefiting the Company | CERO Stock News